Skip to main content

Plasticidad de la masa celular beta en la obesidad y la diabetes tipo 2: papel de las células ductales pancreáticas

PI22/00334

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Salud
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IDIBELL
Execution centre FUNDACION IDIBELL

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Implications of noncoding regulatory functions in the development of insulinomas

  • Ramos-Rodríguez, Mireia
  • Subirana Granés, Marc
  • Norris, Richard|||0000-0001-8446-5507
  • Sordi, Valeria
  • Fernández, Esteve|||0000-0003-4239-723X
  • Fuentes-Páez, Georgina
  • Pérez-González, Beatriz|||0000-0001-9849-5176
  • Berenguer Balaguer, Clara
  • Raurell-Vila, Helena
  • Chowdhury, Murad
  • Corripio, Raquel|||0000-0003-3344-8269
  • Partelli, Stefano
  • López-Bigas, Núria
  • Pellegrini, Silvia
  • Montanya, Eduard|||0000-0003-2518-9076
  • Nacher Garcia, Montserrat|||0000-0002-8458-9275
  • Falconi, Massimo
  • Layer, R.
  • Rovira, Meritxell|||0000-0002-0538-4846
  • González-Pérez, A.
  • Piemonti, Lorenzo|||0000-0002-2172-2198
  • Pasquali, Lorenzo|||0000-0003-2423-1826
Insulinomas are rare neuroendocrine tumors arising from pancreatic β cells, characterized by aberrant proliferation and altered insulin secretion, leading to glucose homeostasis failure. With the aim of uncovering the role of noncoding regulatory regions and their aberrations in the development of these tumors, we coupled epigenetic and transcriptome profiling with whole-genome sequencing. As a result, we unraveled somatic mutations associated with changes in regulatory functions. Critically, these regions impact insulin secretion, tumor development, and epigenetic modifying genes, including polycomb complex components. Chromatin remodeling is apparent in insulinoma-selective domains shared across patients, containing a specific set of regulatory sequences dominated by the SOX17 binding motif. Moreover, many of these regions are H3K27me3 repressed in β cells, suggesting that tumoral transition involves derepression of polycomb-targeted domains. Our work provides a compendium of aberrant cis-regulatory elements affecting the function and fate of β cells in their progression to insulinomas and a framework to identify coding and noncoding driver mutations.